FibroGen
Stock Forecast, Prediction & Price Target
FibroGen Financial Estimates
FibroGen Revenue Estimates
FibroGen EBITDA Estimates
FibroGen Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $235.30M N/A | $140.73M -40.19% | $147.75M 4.98% | Avg: $152.44M Low: $146.95M High: $157.62M avg. 3.17% | Avg: $179.47M Low: $173.01M High: $185.58M avg. 17.73% | Avg: $212.97M Low: $205.31M High: $220.22M avg. 18.66% | |
Net Income
% change YoY
| $-291.03M N/A | $-295.22M -1.44% | $-284.23M 3.72% | Avg: $-93.89M Low: $-103.14M High: $-78.81M avg. 66.96% | Avg: $-70.74M Low: $-72.14M High: $-65.85M avg. 24.65% | Avg: $106.05M Low: $101.09M High: $110.74M avg. 249.90% | |
EBITDA
% change YoY
| $-288.53M N/A | $-282.82M 1.97% | $-261.40M 7.57% | Avg: $-130.71M Low: $-135.16M High: $-126.01M avg. 49.99% | Avg: $-153.89M Low: $-159.13M High: $-148.36M avg. -17.73% | Avg: $-182.62M Low: $-188.84M High: $-176.05M avg. -18.66% | |
EPS
% change YoY
| -$3.15 N/A | -$3.15 0% | -$2.92 7.30% | Avg: -$0.94 Low: -$1.06 High: -$0.81 avg. 67.97% | Avg: -$0.71 Low: -$0.74 High: -$0.68 avg. 24.06% | Avg: $1.09 Low: $1.04 High: $1.14 avg. 253.50% | |
Operating Expenses
% change YoY
| $510.96M N/A | $421.47M -17.51% | $398.11M -5.54% | Avg: $101.34M Low: $97.70M High: $104.79M avg. -74.54% | Avg: $119.32M Low: $115.02M High: $123.38M avg. 17.73% | Avg: $141.59M Low: $136.50M High: $146.41M avg. 18.66% | |
FAQ
What is FibroGen stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 113.83% in 2025-2027.
We have gathered data from 2 analysts. Their low estimate is -103.14M, average is -93.89M and high is -78.81M.
What is FibroGen stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 13.19% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is $146.95M, average is $152.44M and high is $157.62M.
What is FibroGen stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 115.18% in 2025-2027.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.06, average is -$0.94 and high is $-0.81.
What is the best performing analyst?
In the last twelve months analysts have been covering FibroGen stock. The most successful analyst is Annabel Samimy.